Логин: Пароль: ?
 
Продукты питания Ткань, одежда, обувь, постельное белье, текстиль Строительные материалы Бумага, пластик, промтовары Биотопливо Продукция для сельского хозяйства, зоотовары Косметика, средства гигиены Медицинские товары и препараты, лекарства Иное

 

Наши партнеры:

 

Новости/Аналитика

Only 6% of hemp-based pharmaceuticals allowed in Denmark

30.06.2020

The fact that to participate in a four-year experimental program to study the possibilities of using the therapeutic properties of hemp for medical purposes, only 12% of the drugs are allowed to be used and 6% are ultimately approved for use speaks volumes. At a minimum, this kind of statistics suggests that not all drugs made on the basis of the therapeutic properties of hemp are safe for health and have therapeutic potential. 

According to published information from the Ministry of Health of the country, 8 out of 63 applications for the admission of pharmaceutical products to the medical program for testing the therapeutic properties of hemp in Denmark have received approval since its inception in 2018. Of the above eight drugs, four more were removed from the already approved list because their manufacturers could not provide supporting documents about their country of origin - Canada.

Hemp products currently available in Denmark

 Approval and compliance with regulatory requirements in the country of origin is the main requirement for the approval of imported hemp pharmaceutical product in accordance with the methodology used in Denmark to decide on the possibility of their use during the above test program. 

It should be noted that 46 out of 63 applications were withdrawn by representatives of the companies themselves that were trying to enter the Danish market or the submitted documents on the therapeutic properties of the provided pharmaceutical products were not recognized by the Danish Medicines Agency (Lægemiddelstyrelse) as sufficient to claim that they are safe for the human body.

There may be a lack of excitement around pharmacological preparations made on the basis of the therapeutic properties of medical hemp, including the fact that this year the leadership of Aurora Cannabis decided to stop the construction of the second stage of a rather large facility for growing and processing medical hemp in Denmark.

Comment of specialists of Ukrainian Technical Hemp Association

The fact that to participate in a four-year experimental program to study the possibilities of using the therapeutic properties of hemp for medical purposes, only 12% of the drugs are allowed to be used and 6% are ultimately approved for use speaks volumes. At a minimum, this kind of statistics suggests that not all drugs made on the basis of the therapeutic properties of hemp are safe for health and have therapeutic potential. It should be noted that if in civilized countries there are minimally acceptable safety criteria for the use of pharmacological preparations made on the basis of the therapeutic properties of hemp and “no more than 10% of officially registered products pass through this sieve,” we can only guess which drugs are sold on the market of our country. . In Ukraine, there are no criteria for the safety of such products, patients cannot demand documents confirming the legitimacy of their sales, officially they cannot provide the buyer with supporting materials for their therapeutic properties, etc. Considering the fact that the four-year experimental program began its implementation in Denmark in 2018, the conclusions and intermediate estimates of the effectiveness of its use, which should be published in 2020, will be extremely interesting. Observing the decreasing number of patients using medications based on the therapeutic properties of hemp (available evidence suggests that the number of patients has decreased by more than three times compared to the second quarter of 2019 in the fourth quarter of 2019), it can be argued that not everything is perfect in this matter “In the Danish kingdom” and it seems worth taking an example from civilized countries in this matter. Those. Before making changes to the current legislation, it is necessary to provide data on the effectiveness of the use of pharmacological preparations made on the basis of the therapeutic properties of hemp, even by well-known foreign companies, and to do this, initiate the conduct of an appropriate type of research in our country.

Обучение в рамках "Конопляного Университета"
13.10.2020

Объявления
Все объявления »
 
 

facebook

telegram

twitter